Encapsulation of Ru(II) Polypyridine Complexes for Tumor-Targeted Anticancer Therapy.

IF 5 Q1 ENGINEERING, BIOMEDICAL
BME frontiers Pub Date : 2023-08-01 eCollection Date: 2023-01-01 DOI:10.34133/bmef.0024
Johannes Karges
{"title":"Encapsulation of Ru(II) Polypyridine Complexes for Tumor-Targeted Anticancer Therapy.","authors":"Johannes Karges","doi":"10.34133/bmef.0024","DOIUrl":null,"url":null,"abstract":"Ru(II) polypyridine complexes have attracted much attention as anticancer agents because of their unique photophysical, photochemical, and biological properties. Despite their promising therapeutic profile, the vast majority of compounds are associated with poor water solubility and poor cancer selectivity. Among the different strategies employed to overcome these pharmacological limitations, many research efforts have been devoted to the physical or covalent encapsulation of the Ru(II) polypyridine complexes into nanoparticles. This article highlights recent developments in the design, preparation, and physicochemical properties of Ru(II) polypyridine complex-loaded nanoparticles for their potential application in anticancer therapy.","PeriodicalId":72430,"journal":{"name":"BME frontiers","volume":"4 ","pages":"0024"},"PeriodicalIF":5.0000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392611/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BME frontiers","FirstCategoryId":"1087","ListUrlMain":"https://doi.org/10.34133/bmef.0024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 1

Abstract

Ru(II) polypyridine complexes have attracted much attention as anticancer agents because of their unique photophysical, photochemical, and biological properties. Despite their promising therapeutic profile, the vast majority of compounds are associated with poor water solubility and poor cancer selectivity. Among the different strategies employed to overcome these pharmacological limitations, many research efforts have been devoted to the physical or covalent encapsulation of the Ru(II) polypyridine complexes into nanoparticles. This article highlights recent developments in the design, preparation, and physicochemical properties of Ru(II) polypyridine complex-loaded nanoparticles for their potential application in anticancer therapy.

Abstract Image

Abstract Image

Abstract Image

Ru(II)多吡啶配合物的包封用于肿瘤靶向抗癌治疗。
Ru(II)多吡啶配合物因其独特的光物理、光化学和生物特性而作为抗癌药物备受关注。尽管它们具有良好的治疗效果,但绝大多数化合物与较差的水溶性和较差的癌症选择性有关。在克服这些药理学限制的不同策略中,许多研究工作都致力于将Ru(II)多吡啶复合物物理或共价包封到纳米颗粒中。本文重点介绍了Ru(II)多吡啶配合物负载纳米颗粒的设计、制备和理化性质的最新进展,以及它们在抗癌治疗中的潜在应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.10
自引率
0.00%
发文量
0
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信